Impact of exposure on outcomes with enfortumab vedotin in patients with locally advanced or metastatic urothelial cancer Meeting Abstract
| Authors: | Petrylak, D. P.; Chia, Y. L.; Yu, E. Y.; Powles, T.; Flaig, T. W.; Loriot, Y.; O'Donnell, P. H.; Heath, E. I.; Kojima, T.; Park, S. H.; Sonpavde, G. P.; Picus, J.; Matsubara, N.; Obara, W.; Chudasama, V.; Poondru, S.; Harrison, M.; Kim, E.; Brancato, S. J.; Rosenberg, J. E. |
| Abstract Title: | Impact of exposure on outcomes with enfortumab vedotin in patients with locally advanced or metastatic urothelial cancer |
| Meeting Title: | 2024 ASCO Annual Meeting |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 42 |
| Issue: | 16 Suppl. |
| Meeting Dates: | 2024 May 31-Jun 4 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2024-06-01 |
| Language: | English |
| ACCESSION: | WOS:001275557401150 |
| PROVIDER: | wos |
| DOI: | 10.1200/JCO.2024.42.16_suppl.4503 |
| Notes: | Meeting Abstract: 4503 -- Source: Wos |
